Product Details

Sandoz Sitagliptin

Sitagliptin Phosphate Monohydrate
25 mg
Tablet


DIN/PIN/NPN

02504049

Manufacturer

Sandoz Canada Inc.

Formulary Listing Date

2023-03-31  

Unit Price

0.8197

Amount MOH Pays

0.8197

Coverage Status

General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product

ODB Formulary Therapeutic Classification

Therapeutic Note

Sitagliptin Phosphate Monohydrate 25 mg Tablet: Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.

ATC Code

A10BH01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02388839 Januvia 3.2787 0.8197
02508656 Apo-Sitagliptin Malate 0.8197 0.8197
02529866 Auro-Sitagliptin 0.8197 0.8197
02534134 Jamp Sitagliptin 0.8197 0.8197
02504049 Sandoz Sitagliptin 0.8197 0.8197
02531631 Taro-Sitagliptin Fumarate 0.8197 0.8197
02529033 Sitagliptin 0.8197 0.8197
02512475 Ach-Sitagliptin 0.8197 0.8197
02522705 Teva-Sitagliptin Malate 0.8197 0.8197
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph